Gemtuzumab ozogamicin, an antibody–drug conjugate is also a progressive medication to treat leukemia patients. Predominantly identified for its effectiveness as a treatment option in the management of acute myeloid leukemia, several Hematologists prescribe this drug. After confirming the CD-33 Positivity, Gemtuzumab is an option often deliberated by the experts. It’s has a very impactful research data in AML, also reflecting in the clinical experience of treating physicians. Mylotarg is the trade identity of Gemtuzumab. Mylotarg 5mg vials are commercially accessible. As per the company Pfizer, which is also the promoter of Mylotarg or Gemtuzumab, it ought to be preserved in 2 to 8 Degrees.
Mylotarg 5mg granted approval by US FDA and EU EMA
Celltech and Wyeth are the companies credited for developing Gemtuzumab way back in 1991. After Pfizer took up this product, it was aggressively pursued for the relevant designated approvals. US FDA had granted its first approval in the year 2000, for patients above sixty years. The company had to withdraw this product due to technical reasons and reaquired its US FDA and EU EMA approvals in 2018. Ever since its reintroduction based on successful clinical data, Mylotarg has been a drug of choice. Adult and pediatric patients can benefit from this medication.
- The documented clinical trial outcomes as well as the clinical practice experience are perceived in favor of Gemtuzumab. It is used both as a single agent and as a combination drug along with other chemotherapy agents. While considering the relevant aspects of Mylotarg cost, the ultimate survival benefits for patients are considered significant.
- There are serious warnings to consider while using this drug as a single agent. As an advanced chemo drug, trade experts believe that Gemtuzumab price has its relevance, while it could enhance better quality of life.
Gemtuzumab in India – Outline of access information
Mylotarg in India is a concern if not a challenge when it comes to accessing the drug. This medicine is yet to be formally registered in India. However Gemtuzumab is often preferred by Hematologists. The inaccessibility of Gemtuzumab in India may be a setback. But all the concerns including Gemtuzumab cost in India can be effectively addressed.
The domestic restrictions of Mylotarg in India shouldn’t deter the therapeutic planning and administration for Indian patients. Thanks to the option of Named Patient Services, patients can always consider the statutory options to procure. Many treating physicians are aware of the due processes and also can lead patients to the right sources. They would do well by seeking references from the physicians and hospital administrators to source Mylotarg or Gemtuzumab in India. Pricing may be subjective of various international developments from time to time.
Reliable procurement of Gemtuzumab in India
Patients planning to go on Mylotarg in India may obtain a formal import license from CDSCO. It’s the agency authorized to validate the authenticity of the Dr’s prescription and permits patients to buy lifesaving medicines. This is only for personal utility. Mostly the countries of Import are US, Turkey and other European nations. Involving a reliable company with experience to import of Gemtuzumab is naturally definitely a wise thing to do. It is equally important to save on time of enquiring from multiple sources. It is also forthcoming to import medicines in adequate quantities. This can turn out to be economical and optimizes time.
Contact Noel Biotech – +91 9677010046 / +91 992977766; email@example.com